
The government today announced its participation in one of the largest initiatives to date to determine effective neuroimaging techniques that will help chart brain changes associated with mild cognitive impairment and Alzheimer’s disease. The announcement comes barely two weeks after Medicare agreed to reimburse for PET studies of suspected Alzheimer’s patients.























